Bigul

Global Health Ltd - 543654 - Results For Financial Year Ended March 31, 2024

Audited Standalone and Consolidated Results for Financial Year ended March 31, 2024
17-05-2024
Bigul

Global Health Ltd - 543654 - Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI LODR, 2015

The Board of Directors of the Company at its meeting held today i.e. Friday, May 17, 2024, has inter alia, considered and approved the following: a) Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Financial Year ended March 31, 2024. ('Results'). The Certified copies of Result along with the Audit Reports from the Statutory Auditors of the Company are enclosed herewith as Exhibit A. Declaration in respect of Audit Reports with unmodified opinion is enclosed herewith as Exhibit B. b) Recommendation of payment of Commission to Independent Directors for approval of Shareholders to be obtained through Postal Ballot. Notice of Postal Ballot, will be sent to all the Shareholders of the Company whose names appear on the Register of Members/List of Beneficial Owners as received from Depositories, as on Friday, May 17, 2024 (''cut-off date'').
17-05-2024
Bigul

Global Health Ltd - 543654 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Secretarial Compliance Report for the Financial Year 2023-24.
15-05-2024
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 read with Schedule III of SEBI Listing Regulations, we would like to inform you that an Earnings Conference Call is scheduled on Monday, May 20, 2024 at 2:00 P.M. (IST) to be hosted by JM Financial, for the fourth quarter and financial year ended March 31, 2024 results of the Company.
14-05-2024
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

Monitoring Agency Report for Quarter ended March 31, 2024
10-05-2024
Bigul

Global Health Ltd - 543654 - Board Meeting Intimation for Consider And Approve The Standalone And Consolidated Audited Financial Results Of The Company For The Fourth Quarter And Financial Year Ended March 31, 2024.

Global Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2024 ,inter alia, to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the Fourth Quarter and Financial Year ended March 31, 2024.
07-05-2024
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Change in Management

Resignation of Senior Management Personnel''s of the Company as per Intimation attached.
12-04-2024
Bigul

Global Health Ltd - 543654 - Compliance Certificate Under Regulation 7(3) Of The Listing Regulations, For The Financial Year Ended March 31, 2024.

Compliance Certificate under Regulation 7(3) of Listing Regulations, for the financial year ended March 31, 2024.
09-04-2024
Bigul

Global Health Ltd - 543654 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, for the quarter ended March 31, 2024.
09-04-2024
Next Page
Close

Let's Open Free Demat Account